Victrex (VCT) Competitors GBX 863 -18.00 (-2.04%) (As of 11:49 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades VCT vs. JMAT, ELM, ESNT, SCPA, TET, SYNT, ZTF, IOF, WCH, and ITXShould you be buying Victrex stock or one of its competitors? The main competitors of Victrex include Johnson Matthey (JMAT), Elementis (ELM), Essentra (ESNT), Scapa Group (SCPA), Treatt (TET), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), and Itaconix (ITX). These companies are all part of the "specialty chemicals" industry. Victrex vs. Johnson Matthey Elementis Essentra Scapa Group Treatt Synthomer Zotefoams Iofina Wilmcote Holdings plc (WCH.L) Itaconix Johnson Matthey (LON:JMAT) and Victrex (LON:VCT) are both basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation, community ranking and dividends. Does the media favor JMAT or VCT? In the previous week, Victrex had 2 more articles in the media than Johnson Matthey. MarketBeat recorded 3 mentions for Victrex and 1 mentions for Johnson Matthey. Johnson Matthey's average media sentiment score of 0.00 beat Victrex's score of -0.53 indicating that Johnson Matthey is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Johnson Matthey 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Victrex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative Does the MarketBeat Community believe in JMAT or VCT? Victrex received 22 more outperform votes than Johnson Matthey when rated by MarketBeat users. Likewise, 63.69% of users gave Victrex an outperform vote while only 62.02% of users gave Johnson Matthey an outperform vote. CompanyUnderperformOutperformJohnson MattheyOutperform Votes48562.02% Underperform Votes29737.98% VictrexOutperform Votes50763.69% Underperform Votes28936.31% Which has higher earnings & valuation, JMAT or VCT? Johnson Matthey has higher revenue and earnings than Victrex. Victrex is trading at a lower price-to-earnings ratio than Johnson Matthey, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJohnson Matthey£12.84B0.21£108M£0.582,615.52Victrex£284.10M2.70£30.70M£0.352,517.14 Which has more volatility & risk, JMAT or VCT? Johnson Matthey has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500. Comparatively, Victrex has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Do insiders & institutionals believe in JMAT or VCT? 66.6% of Johnson Matthey shares are held by institutional investors. Comparatively, 97.1% of Victrex shares are held by institutional investors. 0.6% of Johnson Matthey shares are held by company insiders. Comparatively, 1.6% of Victrex shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is JMAT or VCT more profitable? Victrex has a net margin of 10.81% compared to Johnson Matthey's net margin of 0.84%. Victrex's return on equity of 6.36% beat Johnson Matthey's return on equity.Company Net Margins Return on Equity Return on Assets Johnson Matthey0.84% 4.39% 3.41% Victrex 10.81%6.36%6.59% Do analysts rate JMAT or VCT? Johnson Matthey currently has a consensus price target of GBX 1,993.33, suggesting a potential upside of 31.40%. Victrex has a consensus price target of GBX 1,485, suggesting a potential upside of 68.56%. Given Victrex's higher probable upside, analysts clearly believe Victrex is more favorable than Johnson Matthey.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Johnson Matthey 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Victrex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is JMAT or VCT a better dividend stock? Johnson Matthey pays an annual dividend of GBX 77 per share and has a dividend yield of 5.1%. Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 6.8%. Johnson Matthey pays out 13,275.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. SummaryVictrex beats Johnson Matthey on 11 of the 19 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get Victrex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCT vs. The Competition Export to ExcelMetricVictrexSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£766.73M£7.20B£2.70B£1.39BDividend Yield6.56%4.02%5.23%11.72%P/E Ratio2,517.14304.90118.471,560.64Price / Sales2.70504.18520,707.48208,575.83Price / Cash34.2118.1123.4932.92Price / Book1.671.933.212.84Net Income£30.70M£133.33M£141.83M£152.61M7 Day Performance1.70%1.42%1.76%4.71%1 Month Performance-6.18%-0.64%3.19%3.35%1 Year Performance-40.67%-3.47%25.75%105.68% Victrex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCTVictrex2.521 of 5 starsGBX 863-2.0%GBX 1,485+72.1%-40.7%£751.07M£284.10M2,465.711,109Dividend IncreaseJMATJohnson Matthey2.7103 of 5 starsGBX 1,509+1.4%GBX 1,993.33+32.1%-3.1%£2.63B£12.84B2,601.72N/AELMElementis2.538 of 5 starsGBX 132.80-0.4%GBX 173.33+30.5%+6.9%£782.35M£732.20M-3,320.001,281ESNTEssentra3.1143 of 5 starsGBX 151.40+2.0%GBX 216.67+43.1%-3.3%£434.73M£309.70M7,980.00350Gap UpSCPAScapa GroupN/AGBX 214.50flatN/AN/A£402.98M£281.80M-7.321,461TETTreattN/AGBX 503.06+0.2%GBX 655+30.2%+11.2%£305.46M£143.55M2,794.75350Dividend IncreaseGap DownSYNTSynthomer2.872 of 5 starsGBX 184.40+2.4%GBX 288.33+56.4%-10.8%£301.62M£1.97B-302.304,200ZTFZotefoamsN/AGBX 360flatN/A+23.6%£174.96M£133.40M1,800.00549Gap DownIOFIofinaN/AGBX 19.90+3.4%GBX 35+75.9%-17.0%£38.18M£51.71M1,990.0095WCHWilmcote Holdings plc (WCH.L)N/AGBX 3flatN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 136+11.0%N/A+3.4%£18.35M£6.62M-3,400.0017Gap UpHigh Trading Volume Related Companies and Tools Related Companies Johnson Matthey Alternatives Elementis Alternatives Essentra Alternatives Scapa Group Alternatives Treatt Alternatives Synthomer Alternatives Zotefoams Alternatives Iofina Alternatives Wilmcote Holdings plc (WCH.L) Alternatives Itaconix Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:VCT) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Victrex plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Victrex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
